Effects of Less than 60 Days Delay in Surgery on Tumor Progression and Survival Outcomes in Invasive Breast Cancer Patients
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The effect of delays in surgical treatment on survival outcomes in patients with breast cancer remains uncertain, but it is an issue of importance to both patients and clinicians. The purpose of this study was to determine the impact of delayed surgical treatment on survival and tumor progression such as changes in tumor size and lymph node metastasis. Methods: Among 1,219 patients who underwent breast cancer surgery at Asan Medical Center between January 2008 and December 2008, 1,074 patients were finally included in the study following the application of inclusion and exclusion criteria. Patients were divided into two groups based on the interval between diagnosis and surgery: ≤30 days (group 1) and >30 days (group 2). We retrospectively analyzed clinical characteristics, changes in tumor size and axillary lymph-node status, and overall survival (OS) and disease-free survival (DFS) rates. Results: Between group 1 and group 2, there were no differences in clinical characteristics or in changes in tumor size between findings based on ultrasonography (USG) with biopsy at diagnosis and pathologic results (p=0.134). Furthermore, changes in tumor size and lymph-node status between USG results at Asan Medical Center and pathologic results also showed no differences (p=0.249 and p=0.233, respectively). There were also no significant differences in DFS (p=0.395) or OS (p=0.813). Conclusion: Our study showed that short-term delays of ≤2 months between diagnosis and surgery for breast cancer do not negatively affect cancer progression or survival rates.
Abstract
Purpose: The effect of delays in surgical treatment on survival outcomes in patients with breast cancer remains uncertain, but it is an issue of importance to both patients and clinicians. The purpose of this study was to determine the impact of delayed surgical treatment on survival and tumor progression such as changes in tumor size and lymph node metastasis. Methods: Among 1,219 patients who underwent breast cancer surgery at Asan Medical Center between January 2008 and December 2008, 1,074 patients were finally included in the study following the application of inclusion and exclusion criteria. Patients were divided into two groups based on the interval between diagnosis and surgery: ≤30 days (group 1) and >30 days (group 2). We retrospectively analyzed clinical characteristics, changes in tumor size and axillary lymph-node status, and overall survival (OS) and disease-free survival (DFS) rates. Results: Between group 1 and group 2, there were no differences in clinical characteristics or in changes in tumor size between findings based on ultrasonography (USG) with biopsy at diagnosis and pathologic results (p=0.134). Furthermore, changes in tumor size and lymph-node status between USG results at Asan Medical Center and pathologic results also showed no differences (p=0.249 and p=0.233, respectively). There were also no significant differences in DFS (p=0.395) or OS (p=0.813). Conclusion: Our study showed that short-term delays of ≤2 months between diagnosis and surgery for breast cancer do not negatively affect cancer progression or survival rates.
참고문헌 (12)
- DeSantis C, "Breast cancer statistics, 2013", CA Cancer J Clin, 64, pp.52~62 (2014)
- Yun YH, "The influence of hospital volume and surgical treatment delay on long-term survival after cancer surgery", Ann Oncol, 23, pp.2731~2737 (2012)
- Bleicher RJ, "Preoperative delays in the US Medicare population with breast cancer", J Clin Oncol, 30, pp.4485~4492 (2012)
- Shin DW, "Delay to curative surgery greater than 12 weeks is associated with increased mortality in patients with colorectal and breast cancer but not lung or thyroid cancer", Ann Surg Oncol, 20, pp.2468~2476 (2013)
- Smith EC, "Delay in surgical treatment and survival after breast cancer diagnosis in young women by race", ethnicity, 2013, pp.148, 516~523
- YOO TAE KYUNG R, "Delay of Treatment Initiation Does Not Adversely Affect Survival Outcome in Breast Cancer", Cancer Research and Treatment, 48(3), pp.962~969 (2016), 대한암학회
- Brazda A, "Delays in time to treatment and survival impact in breast cancer", Ann Surg Oncol, 17(Suppl 3), pp.291~296 (2010)
- Eastman A, "Outcomes of delays in time to treatment in triple negative breast cancer", Ann Surg Oncol, 20, pp.1880~1885 (2013)
- Mujar M, "Delays in time to primary treatment after a diagnosis of breast cancer: does it impact survival?", Prev Med, 56, pp.222~224 (2013)
- Edge SB, "The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM", Ann Surg Oncol, 17, pp.1471~1474 (2010)
- Raptis DA, "Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer", Surgeon, 8, pp.239~246 (2010)
- Alberts WM, "American College of Chest Physicians. Lung cancer: practice organization", Chest, 123(1 Suppl), pp.332S~337S (2003)